Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders

Paula Krakowiak1, Cheryl K Walker, Andrew A Bremer

  • 1Division of Epidemiology, Department of Public Health Sciences, University of California, Davis, California, USA. pkrakowiak@ucdavis.edu

Pediatrics
|April 12, 2012
PubMed

Insights

Metabolic conditions during pregnancy, including diabetes, hypertension, and obesity, are linked to increased risks of autism spectrum disorder (ASD) and developmental delays (DD) in children.

Area of Science:

  • Neurodevelopmental disorders
  • Maternal health
  • Pediatric health

Background:

  • Metabolic conditions (MCs) during pregnancy, such as diabetes, hypertension, and obesity, are increasingly prevalent.
  • The association between maternal MCs and offspring neurodevelopmental outcomes, including autism spectrum disorder (ASD) and developmental delays (DD), requires further investigation.

Purpose of the Study:

  • To examine the association between maternal metabolic conditions (diabetes, hypertension, obesity) during pregnancy and the risk of ASD, DD, or specific developmental impairments in offspring.

Main Methods:

  • A population-based, case-control study (CHARGE study) enrolled 517 children with ASD, 172 with DD, and 315 controls aged 2-5 years.
  • Maternal MCs were ascertained via medical records or interviews. Offspring diagnoses were confirmed using standardized assessments.

Main Results:

  • Maternal MCs were more common in mothers of children with ASD and DD compared to controls.
  • Collectively, MCs were associated with a higher likelihood of ASD (OR: 1.61) and DD (OR: 2.35).
  • Offspring exposed to maternal MCs showed significantly lower scores on early learning and adaptive behavior scales.

Conclusions:

  • Maternal metabolic conditions during pregnancy may be broadly linked to neurodevelopmental problems in children.
  • The rising prevalence of obesity highlights these findings as a significant public health concern.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...